Drug Repositioning
Emerging Therapeutics Agents and Recent Advances in Drug Repurposing for Alzheimer's Disease
Ageing Res Rev. 2022 Dec 15:101815. doi: 10.1016/j.arr.2022.101815. Online ahead of print.
NO ABSTRACT
PMID:36529440 | DOI:10.1016/j.arr.2022.101815
Drug repurposing based novel anti-leishmanial drug screening using <em>in-silico</em> and <em>in-vitro</em> approaches
J Biomol Struct Dyn. 2022;40(21):10812-10820. doi: 10.1080/07391102.2021.1950574. Epub 2021 Jul 11.
NO ABSTRACT
PMID:36529188 | DOI:10.1080/07391102.2021.1950574
Contraceptive use and contraceptive counselling interventions for women of reproductive age with cancer: a systematic review and meta-analysis
BMC Med. 2022 Dec 17;20(1):489. doi: 10.1186/s12916-022-02690-w.
NO ABSTRACT
PMID:36528586 | DOI:10.1186/s12916-022-02690-w
Drug repurposing: From the discovery of a useful pharmacological effect to making the treatment available to the patient
Therapie. 2022 Dec 5:S0040-5957(22)00273-6. doi: 10.1016/j.therap.2022.11.009. Online ahead of print.
NO ABSTRACT
PMID:36528417 | DOI:10.1016/j.therap.2022.11.009
Uncovering the gene regulatory network of type 2 diabetes through multi-omic data integration
J Transl Med. 2022 Dec 16;20(1):604. doi: 10.1186/s12967-022-03826-5.
NO ABSTRACT
PMID:36527108 | DOI:10.1186/s12967-022-03826-5
Blood Milieu in Acute Myocardial Infarction Reprograms Human Macrophages for Trauma Repair
Adv Sci (Weinh). 2022 Dec 16:e2203053. doi: 10.1002/advs.202203053. Online ahead of print.
NO ABSTRACT
PMID:36526599 | DOI:10.1002/advs.202203053
Radotinib attenuates TGFβ -mediated pulmonary fibrosis in vitro and in vivo: exploring the potential of drug repurposing
BMC Pharmacol Toxicol. 2022 Dec 15;23(1):93. doi: 10.1186/s40360-022-00634-x.
NO ABSTRACT
PMID:36522756 | DOI:10.1186/s40360-022-00634-x
Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switch
J Immunother Cancer. 2022 Dec;10(12):e005002. doi: 10.1136/jitc-2022-005002.
NO ABSTRACT
PMID:36521927 | DOI:10.1136/jitc-2022-005002
Synergistic Combinations of FDA-Approved Drugs with Ceftobiprole against Methicillin-Resistant Staphylococcus aureus
Microbiol Spectr. 2022 Dec 15:e0372622. doi: 10.1128/spectrum.03726-22. Online ahead of print.
NO ABSTRACT
PMID:36519895 | DOI:10.1128/spectrum.03726-22
Molecular dynamics simulation and docking analysis of NF-κB protein binding with sulindac acid
Bioinformation. 2022 Mar 31;18(3):170-179. doi: 10.6026/97320630018170. eCollection 2022.
NO ABSTRACT
PMID:36518123 | PMC:PMC9722428 | DOI:10.6026/97320630018170
Design, synthesis, biological evaluation and crystal structure determination of dual modulators of carbonic anhydrases and estrogen receptors
Eur J Med Chem. 2022 Dec 6;246:115011. doi: 10.1016/j.ejmech.2022.115011. Online ahead of print.
NO ABSTRACT
PMID:36516582 | DOI:10.1016/j.ejmech.2022.115011
A network medicine approach for identifying diagnostic and prognostic biomarkers and exploring drug repurposing in human cancer
Comput Struct Biotechnol J. 2022 Nov 29;21:34-45. doi: 10.1016/j.csbj.2022.11.037. eCollection 2023.
NO ABSTRACT
PMID:36514340 | PMC:PMC9732137 | DOI:10.1016/j.csbj.2022.11.037
Vir2Drug: a drug repurposing framework based on protein similarities between pathogens
Brief Bioinform. 2022 Dec 13:bbac536. doi: 10.1093/bib/bbac536. Online ahead of print.
NO ABSTRACT
PMID:36513376 | DOI:10.1093/bib/bbac536
Potential target identification for osteosarcoma treatment: Gene expression re-analysis and drug repurposing
Gene. 2022 Dec 10:147106. doi: 10.1016/j.gene.2022.147106. Online ahead of print.
NO ABSTRACT
PMID:36513192 | DOI:10.1016/j.gene.2022.147106
Drug repurposing in skeletal muscle ion channelopathies
Curr Opin Pharmacol. 2022 Dec 10;68:102329. doi: 10.1016/j.coph.2022.102329. Online ahead of print.
NO ABSTRACT
PMID:36512979 | DOI:10.1016/j.coph.2022.102329
Age, gender and degree of inclusion are predictors of timing for spontaneous repositioning of intruded primary teeth in pre-school children
Eur J Paediatr Dent. 2022 Dec;23(4):269-274. doi: 10.23804/ejpd.2022.23.04.03.
NO ABSTRACT
PMID:36511905 | DOI:10.23804/ejpd.2022.23.04.03
Repurposing FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, and remdesivir as potential inhibitors against RNA dependent RNA polymerase of SARS-CoV-2: A comparative in silico perspective
Inform Med Unlocked. 2022 Dec 8:101147. doi: 10.1016/j.imu.2022.101147. Online ahead of print.
NO ABSTRACT
PMID:36510496 | PMC:PMC9729590 | DOI:10.1016/j.imu.2022.101147
Phenotypic screening of 1,953 FDA-approved drugs reveals 26 hits with potential for repurposing for Peyronie's disease
PLoS One. 2022 Dec 12;17(12):e0277646. doi: 10.1371/journal.pone.0277646. eCollection 2022.
NO ABSTRACT
PMID:36508413 | DOI:10.1371/journal.pone.0277646
Cellular Genome-Scale Metabolic Modeling Identifies New Potential Drug Targets Against Hepatocellular Carcinoma
OMICS. 2022 Dec;26(12):671-682. doi: 10.1089/omi.2022.0122.
NO ABSTRACT
PMID:36508280 | DOI:10.1089/omi.2022.0122
Montelukast Inhibits Lung Cancer Cell Migration by Suppressing Cysteinyl Leukotriene Receptor 1 Expression In Vitro
Curr Pharm Biotechnol. 2022 Dec 7. doi: 10.2174/1389201024666221207143513. Online ahead of print.
NO ABSTRACT
PMID:36503460 | DOI:10.2174/1389201024666221207143513